News

Clinical trials often fail due to poor design and / or endpoint selection. These challenges are often amplified in the rare disease field, where substantial patient heterogeneity exists. In this webinar we will explain the evolution of wearable technologies and digital endpoints, outlining their potential advantages over conventional measurements and monitoring of patients at clinical … Continued

Today, Healx is proud to launch a new and expanded version of the Rare Treatment Accelerator (RTA), its innovative partnership programme which connects academic groups, patient groups and early-stage biotechs with Healx’s team of experts to unlock the power of repurposed drugs for rare diseases – 95% of which are still without an approved treatment.  … Continued